Literature DB >> 28938223

The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians.

Seon Young Kim1, Kwantae Kim2, Byungjin Hwang3, Kyongok Im2, Si Nae Park2, Jung-Ah Kim4, Sang Mee Hwang5, Duhee Bang3, Dong Soon Lee6.   

Abstract

Mutational profiles of 153 Korean myelodysplastic syndrome (MDS) patients were investigated. Sequencing of 87 genes presented similar mutational profiles in Korean MDS patients compared with previous reports. The most frequently mutated genes were ASXL1 (22.9%), U2AF1 (16.3%), TP53 (13.7%), RUNX1 (10.5%), TET2 (10.5%), DNMT3A (8.5%), and SRSF2 (8.5%). The U2AF1 mutation frequency was higher, with different frequencies in the mutated sites of U2AF1 (S34Y, 6/25; S34F, 11/25; and Q157P 8/25). The U2AF1 S34Y mutation was strongly associated with isolated trisomy 8 (5/6, 83%) and was characterized by a younger age of MDS onset (median, 39 years). The S34F mutation was associated with trisomy 8 (6/11, 55%) and del(20q) (3/11, 27%). Data from 10 literatures (total 3460 patients) of 229 U2AF1-mutated cases revealed a significant association between the S34Y and trisomy 8 in Asians (P=0.0001), but not in Caucasians (P=0.080). We infer that U2AF1 S34 mutations characterize a distinct subgroup of MDS: younger age of onset and differential associations with particular cytogenetic aberrations depending on specific mutations [S34Y to +8; S34F to +8 and del(20q)]. The impact and causal relationship between U2AF1 S34 and trisomy 8 need to be elucidated, which might contribute to design of tailored treatments.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mutational profile; Myelodysplastic syndrome; S34Y; Trisomy 8; U2AF1

Mesh:

Substances:

Year:  2017        PMID: 28938223     DOI: 10.1016/j.leukres.2017.09.001

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression.

Authors:  Ning Dou; Dong Yang; Shijun Yu; Binghao Wu; Yong Gao; Yandong Li
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

2.  Gene mutation spectrum of patients with myelodysplastic syndrome and progression to acute myeloid leukemia.

Authors:  Ming Liu; Fang Wang; Yang Zhang; Xue Chen; Panxiang Cao; Daijing Nie; Jiancheng Fang; Mingyu Wang; Mingyue Liu; Hongxing Liu
Journal:  Int J Hematol Oncol       Date:  2021-06-22

3.  Myelodysplastic syndrome transforming to atypical chronic myeloid leukemia shows changes in its mutation allele frequency and acquisition of new mutations.

Authors:  Hakim Nm; Tam W; Philipovskiy A; Tonk V; Orazi A
Journal:  Leuk Res Rep       Date:  2021-05-18

4.  Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis.

Authors:  Bixia Li; Duobing Zou; Shujun Yang; Guifang Ouyang; Qitian Mu
Journal:  J Int Med Res       Date:  2019-12-11       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.